Neurobiology of Stress-Induced Nicotine Relapse.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and mechanistic research
PubMed 38338760 · doi:10.3390/ijms25031482
What was done
This narrative review summarizes recent preclinical findings regarding the neurobiology, molecular targets, potential therapeutics, and modulating factors involved in stress-induced relapse to nicotine seeking.
What was found
The abstract reports no numerical data. It highlights several molecular targets implicated in stress-induced nicotine relapse: alpha3beta4 nicotinic acetylcholine receptors, alpha2-adrenergic receptors, cannabinoid receptor 1, trace amine-associated receptor 1, and neuropeptide systems including corticotropin-releasing factor and dynorphin/kappa opioid receptors.
Why it matters
Understanding the molecular interactions between stress and reward pathways helps identify potential pharmacological targets to reduce smoking relapse rates.
Limits
The abstract describes a non-systematic narrative review based primarily on preclinical animal research, without quantitative synthesis, sample sizes, or direct human clinical trial results.
Cited by
- supports Addiction relapse is most likely to occur during periods of stress, such as interpersonal conflict or sleep deprivation.